| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 19.328 | 24.631 | 28.966 | 35.625 | 35.165 | 33.282 | 40.606 | 52.848 | 58.465 |
| Total Income - EUR | - | 19.328 | 24.631 | 28.966 | 35.738 | 35.165 | 33.282 | 40.606 | 52.848 | 58.466 |
| Total Expenses - EUR | - | 15.480 | 21.480 | 31.645 | 31.803 | 33.082 | 36.683 | 32.251 | 37.445 | 45.879 |
| Gross Profit/Loss - EUR | - | 3.848 | 3.150 | -2.679 | 3.935 | 2.083 | -3.401 | 8.355 | 15.403 | 12.586 |
| Net Profit/Loss - EUR | - | 3.655 | 2.904 | -2.969 | 3.577 | 1.749 | -3.734 | 7.957 | 14.954 | 10.290 |
| Employees | - | 2 | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Bârgu Med Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 3.438 | 2.284 | 22.995 | 15.031 | 8.077 | 1.580 | 0 | 0 | 0 |
| Current Assets | - | 2.557 | 3.181 | 2.590 | 3.099 | 3.325 | 2.722 | 12.164 | 19.422 | 14.442 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.849 | 2.003 | 2.223 | 2.489 | 2.660 | 2.485 | 3.215 | 12.969 | 5.659 |
| Cash | - | 708 | 1.178 | 367 | 610 | 665 | 236 | 8.949 | 6.453 | 8.783 |
| Shareholders Funds | - | 3.700 | 3.695 | 659 | 4.223 | 5.892 | 2.027 | 9.990 | 15.008 | 10.372 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.295 | 1.769 | 24.926 | 13.907 | 5.510 | 2.274 | 2.174 | 4.414 | 4.070 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Bârgu Med Consult Srl